Filter
55
Filtered Results: 55
Text search:
psychostimulant
Featured
Recommendations
6
New Publications
4
Language
Document type
No document type
42
Studies & Reports
6
Guidelines
5
Manuals
2
Countries / Regions
Kenya
1
Togo
1
Global
1
Germany
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Authors & Publishers
Publication Years
Category
MPOX - Monkeypox
2
Palliative Care
1
Countries
1
Health System Strengthening
1
Policies
1
Palliative Care
1
General Guidelines
1
Non-communicable Diseases
1
Toolboxes
Children/Adolescents Mental Disorders
18
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
17
Substance Use Disorders & Addiction
13
Substance Use Disorders, Others
9
Diverse Chemical Substances
4
Drugs
2
Schizophrenia
2
Germany
2
mhGAP Guides
2
People who injecting Drugs
2
Attention deficit hyperactivity disorder (ADHD)
2
Stress
2
IEC Substance Use Disorders
2
Cannabis
2
MPOX - Monkeypox
2
Global Overview
2
HIV in Key Populations
2
Alcohol
1
Cocaine
1
Posttraumatic stress disorder Adults
1
Mental Health
1
Policies & Programmes
1
Training Manuals
1
Eating Disorders
1
Opoids
1
Human Rights
1
Mental Health Guidelines
1
Epilepsy
1
Medical professionals
1
Reports
1
General
1
Waste Managment
1
Reports & Studies
1
Health Worker
1
Policies and guidelines
1
General
1
Community Worker
1
Mental disorders, others
1
TB/HIV Coinfection
1
Tobacco
1
HIV service delivery
1
Depression
1
Mental Health GAP Action Programme
1
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
Q1: Are brief psychosocial interventions for people using cannabis or psychostimulants effective in reducing drug use, dependence and harm from drug use?
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use has changed over time, and we are presenting the estimates of their impact on health. Collectively, smoking, alcohol and illicit drug use kills 11.8...
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
Other disorders Chapter H.1
Autres troubles
Chapitre H.1
Edition en français
Traduction : Priscille Gérardin et Malaïka Lasfar Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Practical Guidance for collaborative interventions
Q7: What is the effectiveness, safety and role of pharmacological and non-pharmacological interventions, within non- specialist health care for children with a diagnosis of Attention-deficit hyperactivity disorder (ADHD)?
2nd revised edition. Accessed Apri. 17, 2019
Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ...
Externalising disorders
Chapter D.3
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
EMCDDA Insights - 11
Accessed: 14.03.2019
Manual for use in primary care.
There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural relevance for substances other than alcohol or tobacco,...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
